Lupin Limited
LUPIN
Kedudukan dalam Saham
#2100
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Harga Saham
$21.44
Modal Pasaran
$9.81B
Perubahan (1 hari)
0.19%
Perubahan (1 tahun)
-2.83%
Negara
IN
Perdagangan Lupin Limited (LUPIN)
Kategori
Healthcare
Nisbah P/B bagi Lupin Limited (LUPIN)
Nisbah P/B pada October 2026 TTM: 4.01
Menurut laporan kewangan dan harga saham terkini Lupin Limited, nisbah P/B semasa (TTM) ialah 4.01. Pada akhir 2024, nisbah P/B syarikat ialah 5.20.
Sejarah nisbah P/B untuk Lupin Limited dari 2004 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 4.01 | -22.82% |
| 2025 | 5.20 | 0.14% |
| 2024 | 5.20 | 119.66% |
| 2023 | 2.37 | -15.25% |
| 2022 | 2.79 | -16.71% |
| 2021 | 3.35 | 57.38% |
| 2020 | 2.13 | -15.55% |
| 2019 | 2.52 | -2.50% |
| 2018 | 2.59 | -46.46% |
| 2017 | 4.83 | -19.02% |
| 2016 | 5.96 | -41.29% |
| 2015 | 10.16 | 68.45% |
| 2014 | 6.03 | 10.74% |
| 2013 | 5.45 | -7.55% |
| 2012 | 5.89 | 4.11% |
| 2011 | 5.66 | 3.72% |
| 2010 | 5.46 | 37.73% |
| 2009 | 3.96 | 24.56% |
| 2008 | 3.18 | -42.95% |
| 2007 | 5.57 | -14.64% |
| 2006 | 6.53 | 45.52% |
| 2005 | 4.49 | -25.91% |
| 2004 | 6.06 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 25.60% |
IN
|
